PIs Introduction

  • Yingmei Lu

    Professor, PhD Supervisor
  • Profile
  • Research Directions
  • Teaching & Courses
  • Research Projects (PI)
•PhD from Tohoku University (Japan), with long-term research experience in the mechanisms of cerebrovascular and neuropsychiatric diseases.
•Has published over 50 representative SCI papers in the past five years, and served as corresponding author for research articles in international top journals including Neuron, Molecular Psychiatry, STTT, J Pineal Res, and J Exp Med.
•Academic Positions: International Editorial Board Member of the SCI journal Journal of Pharmacological Sciences; Visiting Professor at Tohoku University (Japan); Secretary and Vice Chair of the Cerebrovascular Function and Diseases Branch of the Chinese Society for Neuroscience; Vice Chair of the Microcirculation Drug Research Committee of the Chinese Society of Microcirculation; Member of the Neuropsychopharmacology Committee, Chinese Society of Pharmacology; Member of the Cardiovascular Pharmacology Committee, Chinese Society of Pharmacology; Member of the Biomedical Photonics Committee, Chinese Optical Society; Member of the Neurotoxicology Committee, Chinese Society of Toxicology.
•Honors & Talent Programs: Recipient of the First Prize of Natural Science Award from the Ministry of Education; Principal Investigator (PI) of multiple projects funded by the National Natural Science Foundation of China (NSFC); Lead Researcher of a Major Project under the Ministry of Science and Technology’s Sci-Tech Innovation 2030 – “Brain Science and Brain-Like Research” Initiative; Selected for the Jiangsu Provincial “Double Innovation Talent” Program.
 
1.Pathogenesis of cerebrovascular-related diseases (stroke and vascular cognitive impairment) and discovery of drug targets
2.Pathogenesis of neuropsychiatric diseases and discovery of drug targets
 
•Graduate Courses:
PhD Supervisor Forum: Modern Biological Technologies and Applications
•Undergraduate Courses:
Physiology (for clinical medicine and basic medicine majors)
1.2022–2025: National Key R&D Program – Investigating mechanisms of cognitive dysfunction from abnormal intercellular communication.
2.2022–2026: Sci-Tech Innovation 2030 – Decoding brain region connections in social disorder pathogenesis.
3.2020–2023: NSFC General Program – Studying CDK5 signaling loss in cerebrovascular endothelial cells and its link to epilepsy.
4.2017–2020: NSFC General Program – Exploring TIGAR signaling imbalance in dementia affecting brain microvascular proteins.
5.2015–2018: NSFC General Program – Investigating post-ischemic microvascular reconstruction via pericyte GPR124 signaling.